Axon Capital LP Ptc Therapeutics, Inc. Transaction History

Axon Capital LP

  • $22.9 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$35.36 - $41.86 $7.04 Million - $8.33 Million
-199,100 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$33.82 - $48.17 $578,322 - $823,707
-17,100 Reduced 7.91%
199,100 $6.73 Million
Q2 2019

Aug 14, 2019
BUY
$35.42 - $45.0 $1.79 Million - $2.27 Million
50,400 Added 30.4%
216,200 $9.73 Million
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $4.66 Million - $6.55 Million
165,800 New
165,800 $6.24 Million

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.24B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Axon Capital LP Portfolio

Follow Axon Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axon Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Axon Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email